Charles A Leath

Summary

Affiliation: Walter Reed Army Medical Center
Country: USA

Publications

  1. ncbi request reprint A multi-institutional review of outcomes of endometrial stromal sarcoma
    Charles A Leath
    Department of Obstetrics, Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 105:630-4. 2007
  2. doi request reprint Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    Int J Gynecol Cancer 19:888-91. 2009
  3. ncbi request reprint Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy
    Jacob M Estes
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama Birmingham, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Am Coll Surg 203:527-32. 2006
  4. ncbi request reprint The impact of aborted radical hysterectomy in patients with cervical carcinoma
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 95:204-7. 2004
  5. ncbi request reprint A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, AL 35294, USA
    Gynecol Oncol 104:591-5. 2007
  6. ncbi request reprint Inflammatory pseudotumor of pelvic lymph nodes
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Obstet Gynecol 108:779-82. 2006
  7. ncbi request reprint Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series
    Charles A Leath
    Division of Gynecologic Oncology, University of Alabama at Birmingham, USA
    J Reprod Med 49:71-5. 2004
  8. doi request reprint Surgically managed stage I endometrial cancer in a low-volume center: outcomes and complications in a military residency program
    Beverly G Reed
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brooke Army Medical Center, Ft Sam Houston, TX 78234, USA
    Am J Obstet Gynecol 205:356.e1-5. 2011
  9. doi request reprint Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer
    Jason C Barnett
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, Fort Sam Houston, Texas
    Cancer 119:3653-61. 2013
  10. ncbi request reprint Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rodney P Rocconi
    University of Alabama at Birmingham, 35233, USA
    Oncologist 11:336-41. 2006

Collaborators

Detail Information

Publications50

  1. ncbi request reprint A multi-institutional review of outcomes of endometrial stromal sarcoma
    Charles A Leath
    Department of Obstetrics, Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 105:630-4. 2007
    ..To compare the clinical behavior and outcomes of low- and high-grade endometrial stromal sarcomas (LGESS and HGESS), respectively...
  2. doi request reprint Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
    Int J Gynecol Cancer 19:888-91. 2009
    ..Because most patients will recur distantly, systemic chemotherapy should be considered for patients with early stage uterine carcinosarcoma...
  3. ncbi request reprint Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy
    Jacob M Estes
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama Birmingham, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Am Coll Surg 203:527-32. 2006
    ..Our goal was to determine the morbidity, disease-free survival, and overall survival of patients with bowel resection at primary cytoreductive surgery for advanced epithelial ovarian carcinoma in the era of platinum and taxane chemotherapy...
  4. ncbi request reprint The impact of aborted radical hysterectomy in patients with cervical carcinoma
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 95:204-7. 2004
    ..To determine the impact of an aborted radical hysterectomy on morbidity and overall survival in patients undergoing surgical treatment for early stage cervical carcinoma...
  5. ncbi request reprint A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, AL 35294, USA
    Gynecol Oncol 104:591-5. 2007
    ..To determine the response rate, progression-free survival and toxicity associated with weekly topotecan administered to patients with platinum-sensitive recurrent epithelial ovarian (EOC) in the third-line setting...
  6. ncbi request reprint Inflammatory pseudotumor of pelvic lymph nodes
    Whitney A Spannuth
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Obstet Gynecol 108:779-82. 2006
    ..Inflammatory pseudotumor is a rare benign cause of lymphadenopathy previously reported in several anatomic locations that can simulate malignant neoplasm...
  7. ncbi request reprint Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series
    Charles A Leath
    Division of Gynecologic Oncology, University of Alabama at Birmingham, USA
    J Reprod Med 49:71-5. 2004
    ..To evaluate the incidence of c-kit expression in uterine sarcomas...
  8. doi request reprint Surgically managed stage I endometrial cancer in a low-volume center: outcomes and complications in a military residency program
    Beverly G Reed
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brooke Army Medical Center, Ft Sam Houston, TX 78234, USA
    Am J Obstet Gynecol 205:356.e1-5. 2011
    ..The purpose of this study was to compare operative outcomes and complications for patients with endometrial cancer who underwent staging by laparoscopy vs laparotomy in a low-volume facility...
  9. doi request reprint Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer
    Jason C Barnett
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, Fort Sam Houston, Texas
    Cancer 119:3653-61. 2013
    ....
  10. ncbi request reprint Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients
    Rodney P Rocconi
    University of Alabama at Birmingham, 35233, USA
    Oncologist 11:336-41. 2006
    ....
  11. ncbi request reprint Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy
    Warner K Huh
    University of Alabama at Birmingham, Birmingham, AL 35249, USA
    Gynecol Oncol 91:470-5. 2003
    ..Our aim was to determine the outcomes of Stage I uterine papillary serous carcinoma (UPSC) patients with and without adjuvant therapy after comprehensive surgical staging...
  12. ncbi request reprint Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis
    Rodney P Rocconi
    University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 97:387-94. 2005
    ..To assess the potential effectiveness and medical costs of three common strategies to manage Stage IB2 squamous cell carcinoma of the cervix (CXCA)...
  13. ncbi request reprint Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary
    Kathleen N Moore
    University of Oklahoma, Division of Gynecologic Oncology, 920 SL Young Blvd, Oklahoma City, OK 73104, USA
    Gynecol Oncol 107:398-403. 2007
    ..Primary carcinoma of the fallopian tube (PCFT) is a rare malignancy comprising 1% of genital tract cancers. We sought to compare survival trends between PCFT and ovarian carcinoma (OC) patients (pts) in a matched, case-control comparison...
  14. ncbi request reprint Surgical staging in endometrial cancer
    Tyler O Kirby
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233 7333, USA
    Oncology (Williston Park) 20:45-50; discussion 50, 53-4, 63. 2006
    ..Finally, resection of occult metastasis with surgical staging may improve survival...
  15. doi request reprint Conservative management of postoperative Fever in gynecologic patients undergoing major abdominal or vaginal operations
    James E Kendrick
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, AL 35249 7333, USA
    J Am Coll Surg 207:393-7. 2008
    ..To develop a standardized protocol for management of postoperative fever in gynecology patients to decrease unnecessary diagnostic workups and empiric use of antibiotics...
  16. doi request reprint Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility
    Neil T Phippen
    Division of Gynecologic Oncology, Department of Ob Gyn, San Antonio Military Medical Center, San Antonio, TX, USA
    Gynecol Oncol 131:158-62. 2013
    ....
  17. ncbi request reprint Synchronous primary endometrial and ovarian carcinoma in a patient with marantic endocarditis
    T Michael Numnum
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, AL, USA
    Obstet Gynecol 108:748-50. 2006
    ..There is limited information about the clinical course of patients with NBTE because the majority of cases are found at the time of autopsy...
  18. ncbi request reprint Weekly topotecan and daily thalidomide in patients with recurrent epithelial ovarian cancer: a report of 2 cases
    Neil T Phippen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 3851 Roger Brooke Drive, Ft Sam Houston, TX 78234, USA
    J Reprod Med 54:583-6. 2009
    ..Recently the combination of topotecan and thalidomide was shown to be superior to topotecan alone in terms of response and progression-free survival...
  19. ncbi request reprint Transcriptional blocks limit adenoviral replication in primary ovarian tumor
    Meredith A Preuss
    Division of Human Gene Therapy and The Gene Therapy Center, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Clin Cancer Res 10:3189-94. 2004
    ..We endeavored to identify biological blocks to adenoviral infection and replication in tumor cells...
  20. ncbi request reprint Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer
    Laura J Havrilesky
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA
    Gynecol Oncol 93:429-34. 2004
    ..We wished to evaluate survival and adverse outcomes of patients with stage IB2 cervical cancer treated primarily with radical hysterectomy and lymphadenectomy...
  21. doi request reprint Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer?
    Neil T Phippen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, Fort Sam Houston, TX 78234, USA
    Gynecol Oncol 130:317-22. 2013
    ....
  22. ncbi request reprint Comparison of operative risks associated with radical hysterectomy in pregnant and nonpregnant women
    Charles A Leath
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama School of Medicine, 1700 6th Avenue South, Room 10250, Birmingham, AL 35249, USA
    J Reprod Med 58:279-84. 2013
    ..To compare the operative data and complications of radical hysterectomy performed on pregnant women versus nonpregnant women...
  23. doi request reprint Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix
    Neil T Phippen
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, Fort Sam Houston, TX 78234, USA
    Gynecol Oncol 127:267-72. 2012
    ..We evaluate the cost effectiveness (CE) of these treatment regimens...
  24. doi request reprint Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy
    Angela J Ziebarth
    University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 126:69-72. 2012
    ..Debate continues about optimal management of patients with node-positive stage I cervical cancer. Our objective was to determine if patient outcomes are affected by radical hysterectomy in the modern era of adjuvant chemoradiation...
  25. ncbi request reprint The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 92:215-9. 2004
    ..To assess the morbidity and efficacy of radical parametrectomy (RP) performed following extrafascial hysterectomy in patients with occult cervical carcinoma...
  26. ncbi request reprint Predictors of outcomes for women with cervical carcinoma
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Alabama at Birmingham, 619 19th Street South, OHB538, Birmingham, AL 35249 7333, USA
    Gynecol Oncol 99:432-6. 2005
    ..To determine the impact of race and other factors on the management and outcomes of women treated for cervical cancer in a rural state...
  27. ncbi request reprint Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer
    Jacob M Estes
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 618 South 19th Street, Old Hillman Building Room 538, Birmingham, AL 35233, USA
    Gynecol Oncol 102:338-42. 2006
    ..The objective of this study was to evaluate the activity and toxicity of this novel chemotherapeutic agent in patients with recurrent ovarian carcinoma...
  28. ncbi request reprint Conservative management of stage I endometrial carcinoma after surgical staging
    J Michael Straughn
    Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35249, USA
    Gynecol Oncol 84:194-200. 2002
    ..The aim of this study was to determine the outcomes of Stage I endometrial carcinoma patients who are managed without adjuvant radiation after comprehensive surgical staging...
  29. ncbi request reprint Primary extrarenal rhabdoid tumor of the ovary. A case report
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 340 Old Hillman Building, 619 19th Street South, Birmingham, AL 35249 7333, USA
    J Reprod Med 48:283-6. 2003
    ..Although extrarenal rhabdoid tumors have been documented at multiple extrarenal sites, to our knowledge no primary ovarian cases have been reported...
  30. ncbi request reprint Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 901 19th Street South, Birmingham, AL 35294, USA
    Gynecol Oncol 94:352-62. 2004
    ..The objective of this study was to evaluate the anti-tumor effect of adenovirus-mediated mda-7/IL-24 (Ad.mda-7) gene therapy in ovarian carcinoma and further improve anti-tumor effect by enhancing infectivity of Ad.mda-7...
  31. ncbi request reprint Undifferentiated uterine sarcoma presenting as a pathologic humerus fracture
    Michelle N Gonzalez
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA
    Mil Med 175:691-2. 2010
    ..Undifferentiated uterine sarcomas are rare malignancies often presenting at advanced stage...
  32. doi request reprint Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study
    Neil T Phippen
    Dept of Ob Gyn, Division of Gynecologic Oncology, Ft Sam Houston, TX 78234, USA
    Gynecol Oncol 123:360-4. 2011
    ..Determine if pre-treatment Patient-Generated Subjective Global Assessment (PG-SGA) predicts febrile neutropenia (FN) in gynecologic cancer patients receiving primary combination chemotherapy...
  33. ncbi request reprint Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy
    T Michael Numnum
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 619 19th Street South, OHB 340, Birmingham, AL 35294, USA
    Gynecol Oncol 97:713-5. 2005
    ..Recently, there have been reports of PET scans used in patients with Gestational Trophoblastic Disease (GTD)...
  34. ncbi request reprint A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy?
    T Michael Numnum
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35294 7333, USA
    J Low Genit Tract Dis 9:2-6. 2005
    ..The objective of this study was to determine the incidence of CIN 2 and CIN 3 in patients with an HSIL (CIN 2) Pap smear using a see-and-treat protocol...
  35. doi request reprint Robotic surgery applications in the management of gynecologic malignancies
    William J Lowery
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, San Antonio, Texas, USA
    J Surg Oncol 105:481-7. 2012
    ..The review focuses on surgical length, blood loss, complications, recovery time, and adequacy of surgical staging of robotic-assisted surgery compared to abdominal and non-robotically assisted laparoscopic surgery for malignancies...
  36. ncbi request reprint Uterine leiomyosarcoma metastatic to the thyroid
    Charles A Leath
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama 35249 7333, USA
    Obstet Gynecol 100:1122-4. 2002
    ..Uterine leiomyosarcoma is an aggressive tumor that has a propensity for distant metastasis. Distant sites of spread include the lung, liver, brain, and bone...
  37. doi request reprint Hospice enrollment for terminally ill patients with gynecologic malignancies: impact on outcomes and interventions
    Erin A Keyser
    Division of Gynecologic Oncology, Brooke Army Medical Center, Ft Sam Houston, TX 78234, USA
    Gynecol Oncol 118:274-7. 2010
    ..To determine survival and interventions for patients with non-curative gynecologic malignancies based on supportive care enrollment...
  38. doi request reprint Reaction to a surgical implant foreign body masquerading as recurrent uterine sarcoma
    Abigail T Shaltz
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brooke Army Medical Center, Fort Sam Houston, Texas, USA
    Obstet Gynecol 117:450-2. 2011
    ..The long-term nature of these products is unknown, and they may cause foreign body reactions masquerading as recurrent disease in patients with cancer...
  39. ncbi request reprint Primary lung large cell carcinoma metastatic to the vulva: a case report and review of the literature
    Rodney P Rocconi
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Gynecol Oncol 94:829-31. 2004
    ..Metastatic cancer to the vulva is a rare diagnosis and is estimated to account for 5-8% of all vulvar cancers...
  40. doi request reprint Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials
    Charles A Leath
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 129:251-7. 2013
    ..To review the clinical trial experience with chemotherapy for patients with primary Stage IVB, persistent and recurrent cervical cancer...
  41. ncbi request reprint Protrusio acetabuli presenting as a complex pelvic mass after total hip arthroplasty
    Charles A Leath
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Obstet Gynecol 104:1187-9. 2004
    ..The differential diagnosis in an elderly woman with a complex pelvic mass includes benign and malignant diseases...
  42. doi request reprint Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence
    Jennifer M Orr
    Department of Obstetrics and Gynecology, William Beaumont Army Medical Center, Fort Bliss, TX, USA
    Gynecol Oncol 122:501-4. 2011
    ..To determine the incidence of subsequent abnormal cervical or vaginal cytology and confirmatory histology in women completing five-years of surveillance for cervical cancer without recurrence...
  43. ncbi request reprint Cervical signet-ring cell carcinoma presenting as a synchronous primary carcinoma with uterine adenocarcinoma
    William J Lowery
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Fort Sam Houston, TX 78234, USA
    Mil Med 174:212-3. 2009
    ..Synchronous primary gynecologic tumors are relatively uncommon with the diagnosis often made following initial surgery...
  44. doi request reprint Growing teratoma syndrome: Brief communication and algorithm for management
    Kevin Byrd
    Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA
    Aust N Z J Obstet Gynaecol 53:318-21. 2013
    ..We report five cases of ovarian GTS as examples of the clinical dilemmas encountered with these women and provide recommendations and an algorithm to guide potential management...
  45. ncbi request reprint Transcriptional targeting of tumors with a novel tumor-specific survivin promoter
    Zeng B Zhu
    Division of Human Gene Therapy, Department of Medicine, Pathology, and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham AL 35291, USA
    Cancer Gene Ther 11:256-62. 2004
    ....
  46. ncbi request reprint Complications of indwelling venous access devices in patients with gynecologic malignancies
    Jacob M Estes
    Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL 35249, USA
    Gynecol Oncol 91:591-5. 2003
    ..The purpose of this study was to evaluate the complication rates associated with indwelling venous access devices in patients with gynecologic malignancies...
  47. ncbi request reprint A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis
    Mack N Barnes
    Department of Gynecologic Oncology, University of Alabama at Birmingham, 538 Old Hillman Building, 618 South 20th Street, Birmingham, AL 35233, USA
    Gynecol Oncol 87:57-63. 2002
    ..This study was performed to determine the ability of medroxyprogesterone acetate (Depo-Provera) to reduce the frequency of spontaneously developing reproductive tract adenocarcinoma in the avian model...
  48. ncbi request reprint Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage
    James E Kendrick
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA
    Obstet Gynecol 107:493-6. 2006
    ..Massive obstetric hemorrhage can be catastrophic, with considerable maternal morbidity and mortality...
  49. doi request reprint Malignant pericardial effusion and pericardial tumor involvement secondary to cervical cancer
    Robert M Ore
    Department of Obstetrics and Gynecology, San Antonio Military Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA
    Mil Med 178:e130-2. 2013
    ..Antemortem discovery of a malignant pericardial effusion secondary to cervical cancer is uncommon and management should focus on symptom control...
  50. ncbi request reprint Single-chain antibodies: A therapeutic modality for cancer gene therapy (review)
    Charles A Leath
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, AL, USA
    Int J Oncol 24:765-71. 2004
    ..We will limit our discussion to the role of scFv in targeting molecular processes associated with carcinogenesis...